Lilly (LLY) and ImmuNext Announce Licensing and Research Collaboration

March 26, 2019 4:30 PM
Eli Lilly and Company (NYSE: LLY) and ImmuNext, Inc. today announced a global licensing and research collaboration focused on the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Corporate News Management Comments

Next Articles